Low MHC-I density impairs the homeostatic proliferation of CD8 T cells after HSCT Online publication date: Sat, 28-Feb-2009
by Irlanda Olvera-Gomez, Jorge Vela-Ojeda, Vianney Ortiz-Navarrete
International Journal of Immunological Studies (IJIS), Vol. 1, No. 1, 2009
Abstract: We hypothesise that the modifications in the Major Histocompatibility Class I (MHC-I) expression after Hematopoietic Stem Cell Transplantation (HSCT) might impact on CD8 T cell recovery. To evaluate our proposal, we measured the number of peripheral CD8 T cells and the MHC-I expression on the monocytes from the patients who underwent allogenic or autologous HSCT. Three months after transplantation, almost all of the autologous recipients showed a high density of MHC-I and the CD8 T cell counts were within the normal range. In contrast, allogeneic recipients had low or heterogeneous expression of MHC-I and low numbers of CD8 T cells. Similar patterns were observed even after 6 to 20 months after transplantation. Recent thymic emigrants and serum levels of IL-7 and IL-15 were similar within both groups of patients. Together, our results indicate that Homeostatic Peripheral Expansion (HPE) is the main mechanism to reach the normal numbers of CD8 T cells immediately after HSCT. A high and homogenous expression of MHC-I molecules is required for an optimal HPE.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Immunological Studies (IJIS):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com